Conroy, Andrea L.
Hawkes, Michael T.
Leligdowicz, Aleksandra
Mufumba, Ivan
Starr, Michelle C.
Zhong, Kathleen
Namasopo, Sophie
John, Chandy C.
Opoka, Robert O.
Kain, Kevin C.
Funding for this research was provided by:
Intellectual Ventures/Global Good
Canadian Institutes of Health Research (FDN-148439, Canada Research Chairs Program, Postdoctoral Research Fellowship, Postdoctoral Research Fellowship, Banting Postdoctoral Research Fellowship)
Tesari Foundation
Article History
Received: 13 December 2021
Accepted: 17 May 2022
First Online: 1 July 2022
Declarations
:
: Written informed consent was obtained from the parent or guardian of all study participants. This study was approved by Makerere University School of Medicine Research Ethics Board (SOMREC, REC Protocol # REF 2011–255), the Uganda National Council for Science and Technology (UNCST), and the University Health Network Research Ethics Board (UHN-REB, REB number 12–0039-AE) and was registered on clinicaltrials.gov (identifier: NCT04726826).
: Not applicable.
: KCK and ALC are inventors on a patent related to host biomarkers for early determination of critical or life-threatening response to illness and/or treatment response. Dr. Chandy John is a member of the editorial board of BMC Medicine. All other authors declare no competing interests.